KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Change in Inventory: 2017-2024

Historic Change in Inventory for BeOne Medicines (ONC) over the last 8 years, with Dec 2024 value amounting to $91.5 million.

  • BeOne Medicines' Change in Inventory rose 220.97% to $28.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $102.0 million, marking a year-over-year increase of 1.35%. This contributed to the annual value of $91.5 million for FY2024, which is 35.09% down from last year.
  • Per BeOne Medicines' latest filing, its Change in Inventory stood at $91.5 million for FY2024, which was down 35.09% from $140.9 million recorded in FY2023.
  • In the past 5 years, BeOne Medicines' Change in Inventory registered a high of $153.3 million during FY2021, and its lowest value of $56.7 million during FY2022.
  • For the 3-year period, BeOne Medicines' Change in Inventory averaged around $96.4 million, with its median value being $91.5 million (2024).
  • In the last 5 years, BeOne Medicines' Change in Inventory spiked by 378.48% in 2020 and then crashed by 63.03% in 2022.
  • BeOne Medicines' Change in Inventory (Yearly) stood at $58.9 million in 2020, then surged by 160.30% to $153.3 million in 2021, then tumbled by 63.03% to $56.7 million in 2022, then soared by 148.63% to $140.9 million in 2023, then crashed by 35.09% to $91.5 million in 2024.